Guy’s and St Thomas’ NHS Foundation Trust:企業の戦略的SWOT分析

◆英語タイトル:Guy's and St Thomas' NHS Foundation Trust - Strategic SWOT Analysis Review
◆商品コード:DATA8013737
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月21日
◆ページ数:36
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD125 ⇒換算¥18,250見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥36,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥54,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Guy’s and St Thomas’ NHS Foundation Trust – Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.

Highlights

Guy’s and St Thomas’ NHS Foundation Trust (Guy’s and St Thomas’) is one of the UK’s largest NHS Foundation Trusts. It is made up of two of the London’s recognized teaching hospitals – Guy’s Hospital and St Thomas’ Hospital. The trust offers integrated acute and community healthcare services. Guy’s and St Thomas’ provides hospital services to its local communities in Lambeth, Lewisham and Southwark. It also provides specialist services for patients from across London, the south east and further afield. The trust is a part of King’s Health Partners and has partnerships with other academic partners, local health and care partners, and NHS partners. Guy’s and St Thomas’ is headquartered in London, the UK.

Guy’s and St Thomas’ NHS Foundation Trust Key Recent Developments

Oct 23,2017: Antibiotic resistance is now “common” in urinary tract infections
Oct 11,2017: Promising new target for treatment of psoriasis is safe, study shows
Sep 16,2016: Guy’s and St Thomas’ NHS Foundation Trust: New Non-Executive Director appointed
Sep 14,2016: Biomedical Research Centre funding announced
Aug 11,2016: Jon Findlay to be chief operating officer of Guy’s & St Thomas

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Section 1 – About the Company 5
Guy’s and St Thomas’ NHS Foundation Trust – Key Facts 5
Guy’s and St Thomas’ NHS Foundation Trust – Key Employees 6
Guy’s and St Thomas’ NHS Foundation Trust – Key Employee Biographies 7
Guy’s and St Thomas’ NHS Foundation Trust – Major Products and Services 8
Guy’s and St Thomas’ NHS Foundation Trust – History 13
Guy’s and St Thomas’ NHS Foundation Trust – Company Statement 15
Guy’s and St Thomas’ NHS Foundation Trust – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Section 2 – Company Analysis 17
Guy’s and St Thomas’ NHS Foundation Trust – Business Description 17
Guy’s and St Thomas’ NHS Foundation Trust – Corporate Strategy 18
Guy’s and St Thomas’ NHS Foundation Trust – SWOT Analysis 19
SWOT Analysis – Overview 19
Guy’s and St Thomas’ NHS Foundation Trust – Strengths 19
Guy’s and St Thomas’ NHS Foundation Trust – Weaknesses 20
Guy’s and St Thomas’ NHS Foundation Trust – Opportunities 21
Guy’s and St Thomas’ NHS Foundation Trust – Threats 22
Guy’s and St Thomas’ NHS Foundation Trust – Key Competitors 23
Section 3 – Company’s Lifesciences Financial Deals and Alliances 24
Guy’s and St Thomas’ NHS Foundation Trust, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 24
Guy’s and St Thomas’ NHS Foundation Trust, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 25
Guy’s and St Thomas’ NHS Foundation Trust, Recent Deals Summary 26
Section 4 – Company’s Recent Developments 27
Oct 23, 2017: Antibiotic resistance is now “common” in urinary tract infections 27
Oct 11, 2017: Promising new target for treatment of psoriasis is safe, study shows 28
Sep 16, 2016: Guy’s and St Thomas’ NHS Foundation Trust: New Non-Executive Director appointed 29
Sep 14, 2016: Biomedical Research Centre funding announced 30
Aug 09, 2016: Guy’s and St Thomas’ appoints Chief Operating Officer 31
Aug 05, 2016: Two new Non-Executive Directors join the Board of Directors 32
Jun 22, 2016: Reza Razavi announced as an New Non-Executive Director for Guy’s and St Thomas’ 33
Jun 21, 2016: Dr Patch named President of European Society of Human Genetics 34
Jan 19, 2016: Amanda Pritchard announced as our new Chief Executive 35
Section 5 – Appendix 36
Methodology 36
About GlobalData 36
Contact Us 36
Disclaimer 36

List of Tables
Guy's and St Thomas' NHS Foundation Trust, Key Facts 5
Guy's and St Thomas' NHS Foundation Trust, Key Employees 6
Guy's and St Thomas' NHS Foundation Trust, Key Employee Biographies 7
Guy's and St Thomas' NHS Foundation Trust, Major Products and Services 8
Guy's and St Thomas' NHS Foundation Trust, History 13
Guy's and St Thomas' NHS Foundation Trust, Other Locations 16
Guy's and St Thomas' NHS Foundation Trust, Subsidiaries 16
Guy's and St Thomas' NHS Foundation Trust, Key Competitors 23
Guy's and St Thomas' NHS Foundation Trust, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 24
Guy's and St Thomas' NHS Foundation Trust, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 25
Guy's and St Thomas' NHS Foundation Trust, Recent Deals Summary 26

★海外企業調査レポート[Guy’s and St Thomas’ NHS Foundation Trust:企業の戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Kala Pharmaceuticals Inc (KALA):製薬・医療:M&Aディール及び事業提携情報
    Summary Kala Pharmaceuticals Inc (Kala Pharmaceuticals) is a clinical stage pharmaceutical company that offers nanoparticle-based treatments for ocular diseases affecting both front and back of the eye. The company’s lead program MPP nanosuspension of an ophthalmic corticosteroid is under phase III …
  • Albena AD Albena :企業の戦略・SWOT・財務情報
    Albena AD Albena - Strategy, SWOT and Corporate Finance Report Summary Albena AD Albena - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Corium International Inc (CORI):医療機器:M&Aディール及び事業提携情報
    Summary Corium International Inc (Corium) is a commercial-stage biopharmaceutical company that produces and develops central nervous system pharmaceutical products. The company develops transdermal healthcare products with the help of Corplex technology platform using small molecules. Its products i …
  • Korab Resources Ltd (KOR):企業の財務・戦略的SWOT分析
    Summary Korab Resources Ltd (Korab) is a mining exploration company. The company’s business activities include evaluation, exploration, acquisition, production, and development of mineral resource properties. It explores for gold, potash, silver, tin, copper, rare earths, nickel, lead, zinc, magnesi …
  • Commercial Bank International PSC:企業の戦略・SWOT・財務情報
    Commercial Bank International PSC - Strategy, SWOT and Corporate Finance Report Summary Commercial Bank International PSC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • New Look Retail Group Limited:企業の戦略・SWOT・財務情報
    New Look Retail Group Limited - Strategy, SWOT and Corporate Finance Report Summary New Look Retail Group Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Vermont Electric Cooperative, Inc.:企業の戦略的SWOT分析
    Vermont Electric Cooperative, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • TMX Group Ltd (X)
    TMX Group Ltd (X) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company
  • Mid-America Apartment Communities Inc (MAA):企業の財務・戦略的SWOT分析
    Summary Mid-America Apartment Communities, Inc. (MAA) is a real estate investment company that operates apartment homes. The company is engaged in property development, property management, redevelopment, acquisition, sales, marketing and financing. MAA provides web-based and technology driven suppo …
  • Biotronik SE & Co KG:企業の戦略的SWOT分析
    Biotronik SE & Co KG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Check Point Software Technologies Ltd (CHKP):企業の財務・戦略的SWOT分析
    Check Point Software Technologies Ltd (CHKP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stren …
  • IBEX Technologies Inc (IBT):企業の財務・戦略的SWOT分析
    Summary IBEX Technologies Inc (IBEX) is a manufacturer and marketer of high-purity proprietary enzymes and recombinant from flavobacterium heparinum. The company provides enzymes such as heparinase I, heparinase II, heparinase III, chondroitinase AC and chondroitinase B. Its assays allow for the stu …
  • TriVascular Inc:製品パイプライン分析
    Summary TriVascular Inc (TriVascular), a subsidiary of Endologix Inc is a medical device company that researches, designs and manufactures technologies to provide optimal solutions for endovascular aortic repair. The company’s product comprise endovascular grafts and self-expanding stent grafts; ova …
  • PhoenixBio Co Ltd (6190):企業の財務・戦略的SWOT分析
    Summary PhoenixBio Co Ltd (PhoenixBio) is a life science company that offers medical therapy solutions. The company offers contract study services including dosing of test-compounds, sampling, chemical analysis, in-life phase trials, measurement of human albumin levels, and metabolic enzymes and blo …
  • Mayo Clinic-医療機器分野:企業M&A・提携分析
    Summary Mayo Clinic (Mayo) is a not-for-profit medical practice and medical research organization. It provides comprehensive medical facilities and programs related to patient care services, research and medical education. It offers specialized medical care with medical departments and centers in mo …
  • Physiomics Plc (PYC):製薬・医療:M&Aディール及び事業提携情報
    Summary Physiomics plc (Physiomics) is a computational systems biology services company. It offers Virtual Tumour, which optimizes the dosing and scheduling of oncology drugs in pre-clinical trials, cardiac toxicity services through its EasyAP, a Web-based simulation and analysis tool. It also offer …
  • Abionic SA-医療機器分野:企業M&A・提携分析
    Summary Abionic SA (Abionic) is a medical device company that develops, produces, and markets in vitro diagnostic devices. The company offers products such as abioSCOPE, IVD capsule, abioGUIDE, abioGUIDE application for android, iPhone & iPad, and accessories. Its abioSCOPE in vitro tests are design …
  • Pousadas de Portugal:企業の戦略・SWOT・財務情報
    Pousadas de Portugal - Strategy, SWOT and Corporate Finance Report Summary Pousadas de Portugal - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Wilmar International Ltd (F34):企業の財務・戦略的SWOT分析
    Wilmar International Ltd (F34) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Ampio Pharmaceuticals Inc (AMPE):企業の財務・戦略的SWOT分析
    Summary Ampio Pharmaceuticals Inc (Ampio) formerly Chay Enterprises Inc, operates as a bio pharmaceutical company that discovers and develops novel therapeutic candidates for inflammatory conditions. The company develops compounds that decrease inflammation by inhibiting specific pro-inflammatory co …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆